This summary provides a clear, concise overview of a recent material event reported by NovaBay Pharmaceuticals, Inc. We'll break down the key details of their latest SEC filing (Form 8-K) in plain language, making it easy to understand even if you're new to financial reports.

---

NovaBay Pharmaceuticals, Inc. Material Event - What Happened

Let's explore some recent news from NovaBay Pharmaceuticals, Inc. in a straightforward way.

---

Event Description (what happened)

NovaBay Pharmaceuticals, a specialty pharmaceutical company known for its eye care and dermatological products, has announced a significant corporate action: a 1-for-5 reverse stock split. This means for every five shares of NovaBay stock you currently own, you will now own one share.

It's important to understand that this action does not change the total value of your investment. For example, if you held 5 shares at $1 each ($5 total), you will now hold 1 share at $5 (still $5 total). Think of it like exchanging five $1 bills for one $5 bill – the total value remains the same, just with fewer, higher-value units.

Crucially, NovaBay will pay out cash for any fractional shares resulting from the split, calculated at the closing price on the effective date, rather than rounding them up or down. So, if you end up with, say, 0.8 shares, you will receive cash for that 0.8 portion. The company also issued a new CUSIP number for the post-split shares, which is important for your broker to track the new shares.

To understand the significance of this move, let's consider why companies undertake reverse stock splits. NovaBay clearly stated its primary objective:

• Meeting Exchange Requirements: NovaBay's stock trades on the NYSE American exchange. This exchange, like others, enforces strict rules, including a minimum bid price of $1.00 per share. NovaBay's stock price has traded below this threshold for an extended period, risking "delisting" – removal from the exchange. This reverse split directly aims to boost the per-share price above $1.00 and restore compliance.
• Attracting Broader Investment: Many institutional investors (such as mutual funds or pension funds) have policies against investing in "penny stocks" (stocks trading at very low prices). A higher share price can make the stock appear more attractive to these larger players, potentially increasing demand and liquidity.
• Improving Company Image: A very low stock price can sometimes create the impression that a company is struggling, even if its underlying business performs adequately. A higher price can help improve that perception, though it does not resolve underlying operational challenges.

In essence, this is a strategic move to adjust the stock's appearance and ensure its continued listing on a major exchange, especially after a period of sustained low stock price and operational challenges.

Event Date/Timeline

NovaBay's board of directors officially approved the split and issued a press release on February 11, 2024. Stockholders had previously approved the concept at an annual meeting on October 16, 2023. The effective date for the reverse stock split, when your shares will officially convert, is February 13, 2024, at 5:00 PM Eastern Time. Split-adjusted trading on the NYSE American will commence at market open on February 14, 2024.

Impact Assessment (who/what is affected)

Why does this matter? This event is significant because:

• For the Company: This action helps NovaBay avoid potential delisting from the NYSE American exchange, which is crucial for its public trading status and capital-raising ability. It could also make the stock more appealing to a broader range of investors, potentially increasing its liquidity (the ease with which shares can be bought and sold). However, it's important to remember that a reverse split does not inherently improve the company's underlying business performance or financial health, which has seen recent operational losses.
• For the Stock Price: While the total value of your investment does not change immediately, the stock's price per share will jump significantly. This can sometimes lead to greater stability in the stock price, though it does not guarantee future growth. The market's perception of the company's long-term viability will ultimately determine its performance.
• It's a Signal: Reverse splits often indicate a company's stock price has been struggling. While it's a necessary step for many companies to stay listed, it does not directly address the underlying business performance, which has been challenged by factors like competitive pressures and the need for new product development.

This isn't just about the company itself. Here's who else might feel the ripple effects:

• Employees: While less directly affected, if the split helps the company maintain its public listing and attract more investment, it could contribute to overall company stability and job security. However, the company's ability to return to profitability remains the key factor.
• Customers/Patients: This event will not directly impact NovaBay's products or services, such as their Avenova® and DERMAdoctor® lines. They will continue to access treatments as before.
• Investors/Traders: Your number of shares will decrease, but the price per share will increase proportionally. Your total investment value should remain the same immediately after the split. However, the market's reaction to the split can influence the stock's subsequent performance. Some investors view reverse splits negatively, while others see them as a necessary step for a company to regain footing. Remember the cash payouts for fractional shares.
• Competitors: They will likely observe whether NovaBay's move stabilizes its market position or signals deeper challenges within the specialty pharma sector.

Now that this has happened, what's next for NovaBay?

• The Split Takes Effect: The 1-for-5 reverse stock split officially occurs on February 13, 2024. On that day, your share count will automatically adjust, and trading on the new basis begins February 14th.
• Market Reaction: We will observe how the market reacts to the new, higher share price. Does it attract new investors? Does the price hold steady, or does it continue to fluctuate, potentially falling below the $1.00 threshold again, which is a significant risk?
• Focus on Business & Financials: Ultimately, this move's success depends on NovaBay's underlying business performance. The company must demonstrate a clear strategy for improving its financial health, increasing sales of core products like Avenova and DERMAdoctor, and achieving profitability. Investors will closely watch future earnings reports for signs of revenue growth, cost control, and a path to sustainable positive cash flow.

The story isn't over; this is just the next chapter in NovaBay's journey to maintain its public listing and attract investment, while simultaneously needing to address its core business challenges.

Financial Impact (if applicable)

How does this affect NovaBay's financial statements? A reverse stock split primarily adjusts the number of shares, rather than directly changing the company's overall financial health.

• Outstanding Shares: The total number of shares available for trading will significantly decrease. For every five pre-split shares, there will now be one. This means fewer shares are circulating in the market. The company didn't provide specific numbers for pre-split and post-split outstanding shares in this filing, but this is the general effect.
• Authorized Shares: Companies also have a maximum number of shares they are permitted to issue (authorized shares). Typically, this number is also adjusted proportionally during a reverse split, or it might remain the same, which would change the ratio of issued to unissued shares. The company didn't provide specific details on the adjustment of authorized shares in this filing.
• Par Value: The "par value" per share (a nominal value assigned to shares) typically remains unchanged during a reverse stock split, meaning the aggregate par value of the common stock on the company's balance sheet also remains the same. The company didn't explicitly state details about par value in this filing, but this is standard practice.
• Market Capitalization: Immediately after the split, the company's total value (its market capitalization) should remain largely unchanged. The higher price per share balances out the fewer number of shares.
• Cash for Fractional Shares: NovaBay will pay shareholders cash for any fractional shares they would have received. This means a small cash outflow from the company to those shareholders.
• Earnings Per Share (EPS): With fewer shares outstanding, future earnings per share (or losses per share) will appear higher (or lower, for losses) than without the split. Historical EPS figures will also be retroactively adjusted to ensure fair comparisons.

Key Takeaways for Investors

For those of you watching your portfolios:

• Value vs. Shares: A reverse split changes the number of shares and the price per share, but not the total value of your investment at the moment of the split. If you owned $100 worth of stock before, you should own $100 worth after, just in fewer, higher-priced shares. Be aware of the cash payout for fractional shares.
• Why it's Done: Understand that companies often use reverse splits to meet exchange listing requirements and make a stock more appealing to a broader range of investors, especially after a prolonged period of low stock price.
• Don't Overreact, but Be Realistic: While reverse splits can sometimes carry a negative stigma, they are not always a death knell for a company. However, they also don't guarantee a turnaround. The primary risk is that the stock price may continue to decline post-split if the underlying business issues are not resolved, potentially leading to further delisting concerns down the line.
• Look Beyond the Split: The real question is whether this move helps NovaBay improve its underlying business and financial health. Monitor their future earnings reports, product pipeline, and company news for concrete signs of improved revenue, reduced losses, and a clear strategy for long-term growth in the competitive specialty pharmaceutical market.
• Do Your Own Homework: This report provides the basics, but always conduct further research if you are considering a trade. Examine NovaBay's detailed financial statements (10-K, 10-Q filings), their market position for products like Avenova, and professional analysts' assessments of their future prospects and risks.